Format

Send to

Choose Destination
Science. 2013 May 31;340(6136):1232910. doi: 10.1126/science.1232910.

Accelerating next-generation vaccine development for global disease prevention.

Author information

1
International AIDS Vaccine Initiative (IAVI), New York, NY 10004, USA. wkoff@iavi.org

Abstract

Vaccines are among the greatest successes in the history of public health. However, past strategies for vaccine development are unlikely to succeed in the future against major global diseases such as AIDS, tuberculosis, and malaria. For such diseases, the correlates of protection are poorly defined and the pathogens evade immune detection and/or exhibit extensive genetic variability. Recent advances have heralded in a new era of vaccine discovery. However, translation of these advances into vaccines remains impeded by lack of understanding of key vaccinology principles in humans. We review these advances toward vaccine discovery and suggest that for accelerating successful vaccine development, new human immunology-based clinical research initiatives be implemented with the goal of elucidating and more effectively generating vaccine-induced protective immune responses.

PMID:
23723240
PMCID:
PMC4026248
DOI:
10.1126/science.1232910
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center